Author

J. Kumi-Diaka

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1

Frequent Co-Authors

S. O. Oseni· 2 shared A. Adebayo· 1 shared A. Kwakye· 1 shared F. Ambrin· 1 shared G. A. Laguer· 1 shared J. Betty· 1 shared J. Hartmann· 1 shared M. Pavlovic· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

S. O. Oseni

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintAug 22, 2021

Nucleoside antibiochemotherapy repressed the growth, chemoresistance, survival, and metastatic potentials of castration-resistant prostate cancer cells

S. O. Oseni, G. A. Laguer, F. Ambrin…·J. Kumi-Diaka

This study shows that puromycin and blasticidin inhibit mCRPC cell growth, survival, and metastasis, with synergistic effects when combined with taxanes.

DOI 10.1101/2021.08.22.457225

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJun 16, 2021

Integrative genomic and epigenomic analyses identified IRAK1 as a novel target for chronic inflammation-driven prostate tumorigenesis

S. O. Oseni, O. Adebayo, A. Adebayo…·J. Kumi-Diaka

DOI 10.1101/2021.06.16.447920

humanbulk RNA-seq

𝕏 PostBluesky